GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Syngenta AG (NYSE:SYT) » Definitions » Net Current Asset Value

Syngenta AG (Syngenta AG) Net Current Asset Value : $-11.56 (As of Dec. 2018)


View and export this data going back to 1993. Start your Free Trial

What is Syngenta AG Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Syngenta AG's net current asset value per share for the quarter that ended in Dec. 2018 was $-11.56.

The historical rank and industry rank for Syngenta AG's Net Current Asset Value or its related term are showing as below:

SYT's Price-to-Net-Current-Asset-Value is not ranked *
in the Agriculture industry.
Industry Median: 3.8
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

Syngenta AG Net Current Asset Value Historical Data

The historical data trend for Syngenta AG's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syngenta AG Net Current Asset Value Chart

Syngenta AG Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.15 1.34 0.52 -0.65 -11.56

Syngenta AG Semi-Annual Data
Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 2.13 -0.65 -10.88 -11.56

Competitive Comparison of Syngenta AG's Net Current Asset Value

For the Agricultural Inputs subindustry, Syngenta AG's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syngenta AG's Price-to-Net-Current-Asset-Value Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Syngenta AG's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Syngenta AG's Price-to-Net-Current-Asset-Value falls into.



Syngenta AG Net Current Asset Value Calculation

Syngenta AG's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2018 is calculated as

Net Current Asset Value Per Share(A: Dec. 2018 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(11744-17048-26-0)/461.102
=-11.56

Syngenta AG's Net Current Asset Value (NCAV) per share for the quarter that ended in Dec. 2018 is calculated as

Net Current Asset Value Per Share(Q: Dec. 2018 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(11744-17048-26-0)/461.102
=-11.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syngenta AG  (NYSE:SYT) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Syngenta AG Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Syngenta AG's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Syngenta AG (Syngenta AG) Business Description

Traded in Other Exchanges
N/A
Address
Schwarzwaldalle 215, Basel, CHE, 4058
Formed in 2000 from spin-offs of Novartis' crop-protection and seeds business and AstraZeneca's agrochemical business, Syngenta is a global producer of crop chemicals and seeds. The Swiss company is a leading manufacturer of crop-protection products, making multiple herbicides, insecticides, and fungicides used on a wide variety of crops. Syngenta's seeds business trails rivals, but the company is investing heavily in research and development in an effort to close the technology gap in genetically modified seeds.